Finch Therapeutics Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FNCH research report →
Companywww.finchtherapeutics.com
Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus.
- CEO
- Matthew Blischak
- IPO
- 2021
- Employees
- 1
- HQ
- Somerville, MA, US
Price Chart
Valuation
- Market Cap
- $11.96M
- P/E
- -0.86
- P/S
- 0.00
- P/B
- 1.32
- EV/EBITDA
- -2.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -86.83%
- ROIC
- -38.62%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-13,877,000 · 81.44%
- EPS
- $-8.64 · 81.46%
- Op Income
- $-18,859,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $16.10
- 52W Low
- $2.00
- 50D MA
- $12.77
- 200D MA
- $12.96
- Beta
- 1.17
- Avg Volume
- 3.65K
Get TickerSpark's AI analysis on FNCH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 7, 24 | SMISEK JEFFERY A | other | 383 |
| Jun 7, 24 | SMISEK JEFFERY A | other | 384 |
| May 20, 24 | SMISEK JEFFERY A | other | 3,750 |
| Mar 28, 24 | SMISEK JEFFERY A | sell | 1,600 |
| Mar 28, 24 | SMISEK JEFFERY A | sell | 6,642 |
| Nov 22, 23 | SMISEK JEFFERY A | sell | 1,470 |
| Jun 9, 23 | Blischak Matthew P. | other | 962,899 |
| Jun 8, 23 | Blischak Matthew P. | other | 962,899 |
| Jun 8, 23 | Lange Christian H. | other | 10,000 |
| Jun 8, 23 | SMISEK JEFFERY A | other | 10,000 |
Our FNCH Coverage
We haven't published any research on FNCH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FNCH Report →